Laser Spectroscopy of the Cornea
角膜激光光谱检查
基本信息
- 批准号:6325333
- 负责人:
- 金额:$ 16.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2001
- 资助国家:美国
- 起止时间:2001-05-01 至 2006-04-30
- 项目状态:已结题
- 来源:
- 关键词:biomarker biomedical equipment development biotechnology burns computer assisted diagnosis cornea diagnosis quality /standard fluorescence fluorescence spectrometry histopathology human tissue laboratory rabbit laser spectrometry organ culture refractive keratoplasty technology /technique development time resolved data tissue engineering
项目摘要
DESCRIPTION: (Applicant's Abstract) Dr. Roy Chuck is an M.D., Ph.D. who
obtained his degrees from Columbia University under auspices of the National
Institutes of Health's prestigious Medical Scientist Training Program Prior to
that he obtained an Engineering Science degree from the University of
California al Berkeley. He possesses a unique background that encompasses the
fields of laser spectroscopy, biochemistry and ophthalmology.
The long term objective of this application is to characterize the
spectroscopic properties of the cornea during ultraviolet laser ablation to
allow identification of spectral features that ma3 differentiate normal from
diseased tissue. Specifically, this will be accomplished by the measurement of
laser-induced fluorescence in real-time during 193-nm excimer laser corneal
surger3 in various normal and disease states including chemical burns and
diabetes.
All of the data taken together, besides enhancing our knowledge of the spectral
features of the cornea in various disease states of ocular health, may also
result in the bioengineering development of an instrument to guide the
alteration of excimer laser ablative patterns to achieve more predictable
surgical results by using real-time spectroscopic feedback information.
Much of the work will be accomplished at the Beckman Laser Institute at the
University of California, Irvine which is well equipped to support the in vivo
and clinical studies of excimer laser corneal surgery and vision within this
research program. The Beckman Laser Institute which is located quite close to
the department offices is closely affiliated with the Department of
Ophthalmology. Housed within the Beckman Laser Institute is a clinical excimer
laser that will be used for this study (VISX Star2). In addition, the Beckman
Laser Institute contains a fully equipped vivarium for housing of rabbits, the
experimental animal that will be used in these investigations Core histology
and ultrastructure facilities are also available within the institute.
The UCI Department of Ophthalmology has an active cornea and external disease
service. This clinical practice will provide the patients for the clinical
studies in the final phase of this research.
罗伊·查克博士是医学博士、博士
在国立大学的赞助下从哥伦比亚大学获得学位
卫生研究院享有盛名的医学科学家培训计划
他从加州大学获得了工程科学学位
加州大学伯克利分校。他拥有独特的背景,包括
激光光谱学、生物化学和眼科学领域。
这个应用程序的长期目标是描述
紫外线激光消融术中角膜的光谱特性
允许识别MA3与正常区分的光谱特征
病变组织。具体地说,这将通过测量
193 nm准分子激光角膜激光实时诱导荧光
外科医生3处于各种正常和疾病状态,包括化学烧伤和
糖尿病。
所有的数据放在一起,除了增强我们对光谱的知识
眼部健康的各种疾病状态下的角膜特征,也可以
导致了生物工程仪器的开发,以引导
改变准分子激光消融模式以达到更可预测的效果
通过使用实时光谱反馈信息获得手术结果。
大部分工作将在贝克曼激光研究所完成
加州大学欧文分校,装备精良,支持体内
以及准分子激光角膜手术和视力的临床研究
研究计划。贝克曼激光研究所,距离
该部门的办公室与该部有密切的联系。
眼科。贝克曼激光研究所内有一台临床准分子
这项研究将使用的激光(Visx Star2)。此外,贝克曼
激光研究所包含一个装备齐全的隔膜,用于安置兔子,
将用于这些研究的实验动物核心组织学
研究所内也有超微结构设施。
UCI眼科有活跃的角膜和外部疾病
服务。这一临床实践将为临床患者提供
在本研究的最后阶段进行研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Roy S Chuck其他文献
Inhibition of corneal neovascularization by a peroxisome proliferator-activated receptor-gamma ligand.
过氧化物酶体增殖物激活受体-γ配体抑制角膜新生血管。
- DOI:
- 发表时间:
2005 - 期刊:
- 影响因子:3.4
- 作者:
M. Sarayba;Li Li;Tulaya Tungsiripat;Norman H Liu;P. Sweet;Anup J. Patel;Kathryn E Osann;Amar Chittiboyina;S. Benson;H. Pershadsingh;Roy S Chuck - 通讯作者:
Roy S Chuck
Roy S Chuck的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Roy S Chuck', 18)}}的其他基金
A Novel Therapeutic that Harnesses MIcrotubules to Enhance Corneal Wound Healing Following an Alkaline Burn
一种利用微管促进碱性烧伤后角膜伤口愈合的新型疗法
- 批准号:
9894005 - 财政年份:2019
- 资助金额:
$ 16.98万 - 项目类别: